Global Fund releases mid-year results for HIV, TB, malaria

Download PDF Copy

Jun 10 2010

NewsGuard 100/100 Score

The Global Fund to Fight AIDS, Tuberculosis and Malaria announced mid-year results for HIV and TB treatment as well as for insecticide-treated net (ITN) distribution, Sify News reports. According to the report, by mid-2010 Global Fund-financed programs have:

Provided antiretrovirals to 2.8 million people with HIV/AIDS, a 22% increase over mid-2009;
Treated 7 million people for tuberculosis, a 30% increase over mid-2009; and
Distributed 122 million ITNs to prevent malaria infection, a 39% increase over mid-2009 (6/9).

This article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Disease/Infection News

Tags: AIDS, HIV, HIV/AIDS, HIV-1, Malaria, Tuberculosis

Comments (0)

Download PDF Copy

Suggested Reading

Artemisinin resistance detected in children with severe malaria in Uganda

Artemisinin resistance detected in children with severe malaria in Uganda

Exclusion of indigenous voices hinders HIV progress in Latin America

Exclusion of indigenous voices hinders HIV progress in Latin America

Historical redlining continues to affect HIV treatment in affected communities

Historical redlining continues to affect HIV treatment in affected communities

Study finds artemisinin resistance in African children with severe malaria

Study finds artemisinin resistance in African children with severe malaria

Sweden exceeds UNAIDS HIV goals but faces new challenges

Sweden exceeds UNAIDS HIV goals but faces new challenges

Iron supplements may boost brain development in children with HIV

Iron supplements may boost brain development in children with HIV

Deforestation drives a surge in malaria cases in the Amazon

Deforestation drives a surge in malaria cases in the Amazon

A promising new strategy for malaria drug development

A promising new strategy for malaria drug development

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

New test promises to end malaria